Despite robust evidence to demonstrate that near normoglycaemia minimizes (but does not completely eliminate) the risk of complications, its achievement has proved almost impossible to attain in a real﹚orld setting. HbA1c to date has been used as the gold standard marker of glucose control and...
Aims: Point-of-care (POC) HbA1c is frequently used as a surrogate for serum HbA1c. We aimed to determine if resident management of type 2 diabetes changed after accounting for the + 0.5% margin of error associated with POC HbA1c devices.Methods: Residents were surveyed in an outpatient cli...
The aim of this prospective registry was to identify patient characteristics associated with achieving HbA1c ≤7.0% in a real-life setting 3 months after adding insulin glulisine to previous anti-hyperglycaemic therapies. Methods The API registry included adult patients with T1DM or T2DM who were ...
The terms “Diabetes reversal” and “Diabetes remission” have been used in scientific articles. They connote a glycosylated hemoglobin A1c (HbA1c) level of <6.5% (<48 mmol/mol) for at least 3 months without the usual glucose-lowering pharmacotherapy [13]. The reversal strategy, mechanism, ...